INTRODUCTION
============

MiRNAs form a class of small regulatory RNAs (∼ 21−23 nt) involved in guiding translational repression or cleavage of mRNAs \[[@B1]\]. Biosynthesis of miRNAs is initiated upon transcription of miRNA-encoding genes into primary miRNAs (pri-miRNAs) by RNA polymerase II \[[@B2]\]. Pri-miRNAs are then processed by the nuclear ribonclease (RNase) III Drosha into miRNA precursors (pre-miRNAs) \[[@B3]\]. Following export to the cytoplasm via Exportin 5 \[[@B4]\], the imperfectly paired stem-loop pre-miRNAs are cleaved into miRNA:miRNA\* duplexes by the RNase III Dicer \[[@B5]--[@B8]\]. Based upon the stability of the base pairs at the 5′ ends of the two strands \[[@B9]\], the mature miRNA will be incorporated into the RNA-induced silencing complex (RISC) \[[@B10]\], whereas the opposite miRNA\* strand is encountered much less frequently and is presumably degraded \[[@B1]\]. The mRNA specifically recognized by the RISC will either be cleaved or translationally repressed, depending on whether the miRNA:mRNA pairing is perfect or not \[[@B1]\].

Hundreds of miRNAs have been identified in *Drosophila*, *C elegans* \[[@B11]\], *A thaliana* \[[@B12]\], zebrafish, mice, human cells \[[@B13]--[@B15]\], and viruses \[[@B16]\]. The ability of some of these miRNAs to regulate translation of specific mRNAs has been demonstrated experimentally. For example, cel-let-7 silences *lin-41* mRNA through binding to its 3′ untranslated region (UTR) in *C elegans* \[[@B17]\], whereas miR-196 mediates cleavage of the *HOXB8* mRNA in mouse embryos \[[@B18]\]. A mechanistic insight into miRNA-mediated translational repression was recently provided, as endogenous let-7 miRNPs were shown to inhibit translation initiation \[[@B19]\]. mRNA functional regulation by miRNAs has been involved in various cellular processes, such as leaf morphogenesis in plants, developmental timing and left/right asymmetry in nematodes, cell proliferation and apoptosis in flies, and hematopoietic cell differentiation in mice \[[@B1]\].

In humans, loss of expression of the *FMR1* (fragile mental retardation 1) gene product, the fragile X mental retardation protein (FMRP), is the etiologic factor of the fragile X syndrome, the most frequent cause of inherited mental retardation \[[@B20], [@B21]\]. FMRP is an RNA-binding protein that contains two K-homology (KH) domains and an RGG box and is involved in RNA regulation of translation, RNA transfer, and local modulation of synaptic mRNA translation. However, its exact roles are still unclear and the mechanisms by which it controls translation are poorly understood. FMRP has been reported to behave as a negative regulator of translation both *in vitro* and in vivo \[[@B22]--[@B26]\], and it is deduced that the miRNA-guided RNA silencing pathway could be a cellular process through which FMRP could regulate translation of target mRNAs.

Indeed, a relation between FMRP and components of the RNAi machinery was uncovered. The ortholog of FMRP (dFMR1) was found to be associated with the effector RISC as well as miRNAs in *Drosophila* S2 cells \[[@B27], [@B28]\]. In mammalian cells, FMRP has been reported to be part of a ribonucleoprotein (RNP) complex with miRNAs and Argonaute 2 (Ago2) \[[@B29]\]. However, how FMRP functions in miRNA-mediated translational control remains unknown.

In this study, we have used recombinant proteins to show that human FMRP can accept miRNAs derived from Dicer cleavage and facilitate the formation of specific miRNA: target transition complexes in vitro. Reporter gene silencing assays, using various small regulatory RNAs, revealed the requirement of FMRP for efficient RNAi in vivo. The results obtained with single-stranded (ss) antisense siRNA also support its involvement in an ss siRNP effector complex in mammalian cells.

MATERIALS AND METHODS
=====================

Protein expression, purification, and analysis
----------------------------------------------

Recombinant Dicer \[[@B6]\], FMRP deleted variant ΔKHT, FMRP mutant I304N, and FXR1P \[[@B30]\] proteins were expressed and purified as previously reported. Immunoblot analysis was performed with previously described antibodies recognizing FMRP \[[@B30]\] and FXR1P \[[@B31]\] proteins, and the immunoreactive proteins visualized with peroxydase-labeled affinity-purified goat anti-rabbit or mouse IgG secondary antibody using Western Lightning Chemiluminescent Reagent (PerkinElmer).

Preparation of RNAs
-------------------

For in vitro experiments, all RNA substrates contained 5′-p and 3′-OH ends (for complete sequence and structure information, see Supplementary text available online at DOI 10.1155/JBB/2006/64347). Synthetic RNAs (Dharmacon) devoid of 5′-p were labeled at their 5′ end using T4 polynucleotide kinase (New England Biolabs) and \[*γ*-^32^ P\] ATP (PerkinElmer), and purified by denaturing PAGE. The following siRNA duplexes were used: CLP siRNA (5′-pAGGAGGUCGUACAGAAUUUdtdt) and Dicer siRNA (5′-pUGCUUGAAGCAGCUCUGGAdtdt).

Target RNAs (∼ 60 or ∼ 100 nt), encompassing the miRNA/siRNA binding sites and flanking regions, were synthesized from DNA templates by in vitro transcription using the T7 RNA polymerase (Ambion) and purified by denaturing PAGE. Templates were obtained either by annealing DNA oligonucleotides or by introducing a T7 RNA polymerase promoter by PCR followed by gel purification. The following target RNAs were used: CLP target RNA (nt 414−514, Acc no L54057), Dicer target RNA (nt 353−453, Acc no AJ132261), *lin-41* target RNA (nt 4100−4162, Acc no AF195610), and *HOXB8* target RNA (nt 2237−2297, Acc no X13721).

Prior to use, miRNAs and target RNAs were denatured at 90°C for 2 min and chilled on ice. Pre-miRNAs and miRNA:miRNA\* were renaturated, and complementary strands of siRNA duplexes annealed, by incubation at 95°C for 5 min, and then slowly cooled down to room temperature.

For cell transfection, the siRNA duplexes siRluc (5′-GGCCUUUCACUACUCCUACdtdt) and siCtl (5′-GUAUAAUACACCGCGCUACdtdt) were used, whereas the ss antisense siRNAs asRluc (5′-GUAGGAGUAGUGAAAGGCCdtdt) and asCtl (5′-GUAGCGCGGUGUAUUAUACdtdt) were phosphorylated in vitro using T4 polynucleotide kinase, followed by ethanol precipitation, prior to use.

Dicer RNase assays
------------------

^32^P-labeled pre-miR-31 RNA (40000 cpm) was incubated in the absence or presence of recombinant Dicer (50−400 ng) and/or FMRP (0.18−2.8 *μ*g) with MgCl~2~ (5 mM) at 37°C for 1 h, as described \[[@B6]\]. The samples were analyzed by denaturing PAGE and autoradiography. For the experiments with FMRP, the samples were treated with 40 *μ*g proteinase K (Ambion) at 55°C for 45 min prior to analysis. RNA derived from Dicer cleavage was gel-purified and incubated with increasing amounts of recombinant FMRP (0.35−1.4 *μ*g), without or with BSA (20 *μ*g), for 30 min on ice prior to EMSA analysis.

EMSA
----

^32^P-labeled human GFP siRNA (0.25 pmol), hsa-miR-196a-1 miRNA:miRNA\* duplex (0.50 pmol), or miRNA (0.50 pmol) (40000 cpm) was incubated in the absence or presence of recombinant FMRP (0.35−1.4 *μ*g) for 30 min on ice prior to electrophoretic mobility shift assay (EMSA) analysis, as described \[[@B18]\]. FMRP-RNA complex formation was analyzed by nondenaturing PAGE (6%) and autoradiography, and analyzed quantitatively by AlphaImaging.

RNA strand annealing assays
---------------------------

These assays were adapted from Gabus et al \[[@B32]\]. Briefly, 0.015 pmol of ^32^P-labeled RNA was incubated, with or without target RNA, in the presence of recombinant FMRP, FMRP I304N, FMRP ΔKHT, or FXR1P \[[@B30]\] protein at 1 : 1, 2 : 1, or 4 : 1 (protein:RNA), or BSA (B) at 4 : 1 molar ratio. Assays were performed in 10 *μ*L containing 20 mM Tris-HCl (pH 7.0), 0.1 mM MgCl~2~, 30 mM NaCl, 10 *μ*M ZnCl~2~, 5 mM DTT, 5% Superase-In at 37°C for 10 min. The reaction was stopped by chilling on ice. After adding 0.5 volume of stop mix (20% glycerol, 20 mM EDTA pH 8.0, 0.2% SDS, 0.4 mg/mL yeast tRNA, and 0.25% bromophenol blue) to chase FMRP, the samples were analyzed by nondenaturing 10% PAGE in TBE buffer. The gels were dried and the radioactive RNA complexes were visualized by autoradiography, and analyzed quantitatively by PhosphorImaging.

DNA constructs, cell culture, and luciferase assays
---------------------------------------------------

The psiSTRIKE and psiCHECK vectors were obtained from Promega. Mouse embryonic *Fmr1* KO (STEK TSV-40, 3T3A, 3T6A, or TpBSVE) \[[@B24], [@B30], [@B33]\], *Fxr1* KO (KETS) (to be described elsewhere) and wild-type (Naïves or NIH/3T3) fibroblasts were grown in DMEM supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 units/mL penicillin, and 100 *μ*g/mL streptomycin in a humidified incubator under 5% CO~2~ at 37°C. Expression of FMRP, FXR1P, and actin proteins was verified by Western blot using anti-mAb1C3 \[[@B34]\], mAb2FX \[[@B31]\], and anti-actin AC-40 (Sigma) antibodies, respectively. Cells grown in 12-well plates to 70% confluency were transfected with 0.8 *μ*g of the psiCHECK reporter vector and either 0.0005−0.5 *μ*g of the psiSTRIKE construct using Lipofectamine 2000 (Invitrogen) or 100−400 nM of ss antisense Rluc siRNA (asRluc) or 100 nM of Rluc siRNA duplex (siRluc) using Oligofectamine (Invitrogen). Twenty-four hours later, cells were harvested, lysates were prepared, and Rluc and Fluc activities were measured successively using the Dual-Luciferase Reporter Assay System (Promega).

RESULTS
=======

FMRP acts as an acceptor of miRNAs derived from Dicer cleavage
--------------------------------------------------------------

Dicer activity has been reported to be associated with FMRP in EBV-transformed human B cells \[[@B29]\], suggesting that Dicer and FMRP are part of a complex in vivo. Since FMRP is likely acting downstream of Dicer in the RNA silencing pathway, we asked whether FMRP can act as a miRNA acceptor protein for the ribonuclease Dicer. To test this hypothesis, the ^32^P-labeled miRNA precursor pre-miR-31 was incubated in the presence of recombinant Dicer, which bound ([Figure 1(a)](#fig1){ref-type="fig"}, left panel) and cleaved pre-miR-31 into a ∼ 21-nt RNA product ([Figure 1(a)](#fig1){ref-type="fig"}, center panel). When this ^32^P-labeled RNA derived from Dicer cleavage was gel-purified and incubated with increasing amounts of recombinant FMRP, a gel mobility shift was observed, compatible with the formation of an FMRP-RNA complex ([Figure 1(a)](#fig1){ref-type="fig"}, right panel).

The relative ability of FMRP to interact with RNA species involved in RNA silencing was further quantified by EMSA. Initial analyses showed that recombinant FMRP associates with the human immunodeficiency virus transactivating response DNA \[[@B32]\] and RNA (I Plante and P Provost, unpublished data) structure, the latter of which closely resembles that of a pre-miRNA. We observed that FMRP preferentially recognized mature miRNA ([Figure 1(b)](#fig1){ref-type="fig"}, right), as monitored by the concomitant decrease in unbound RNA levels. Under these conditions, FMRP only weakly bound a perfect siRNA ([Figure 1(b)](#fig1){ref-type="fig"}, left), or an imperfect miRNA:miRNA\* ([Figure 1(b)](#fig1){ref-type="fig"}, center) duplex. These results confirm the ability of FMRP to bind to the effector mature miRNA.

FMRP assembles miRNAs and ss siRNAs on target RNAs in vitro
-----------------------------------------------------------

Given the ability of FMRP to interact with several hundreds of mRNAs \[[@B35], [@B36]\] and its recently described nucleic acid chaperone properties \[[@B32]\], we asked if FMRP could facilitate the assembly of miRNAs on target RNAs. To this end, single miRNA strands were incubated with a specific target RNA in the presence or absence of recombinant FMRP. Formation of imperfectly paired miRNA:target RNA complexes was visualized by nondenaturing PAGE after FMRP removal. We observed FMRP-mediated assembly of cel-let-7 ([Figure 2(a)](#fig2){ref-type="fig"}, left panel) and hsa-miR-196a-1 ([Figure 2(a)](#fig2){ref-type="fig"}, right panel) miRNAs on their specific 60-nt RNA targets. No annealing was observed in the presence of bovine serum albumin (BSA) ([Figure 2(a)](#fig2){ref-type="fig"}, 7th lane of each panel) or when the cel-let-7 target *lin-41* was swapped with that of hsa-miR-196a-1 (*HOXB8*) ([Figure 2(a)](#fig2){ref-type="fig"}, last lane of each panel). Whether this activity could be extended to siRNAs was tested using siRNAs directed against Dicer and coactosin-like protein (CLP) mRNAs. In both cases, assembly of single siRNA strands on their 100-nt RNA targets was observed ([Figure 2(b)](#fig2){ref-type="fig"}), but not when the targets were interchanged ([Figure 2(b)](#fig2){ref-type="fig"}, last lane of each panel). Used as hybridization control reactions, temperature-mediated annealing of ss siRNAs to their targets was superior to that of miRNAs, as expected considering the increased stability of perfectly complementary ss siRNA:target RNA versus imperfect miRNA:target RNA duplexes. In contrast, FMRP favored annealing of miRNAs to their targets, more than that of ss siRNAs (compare [Figure 2(a)](#fig2){ref-type="fig"} versus [Figure 2(b)](#fig2){ref-type="fig"}), thereby illustrating its preference for imperfect, but natural miRNA:target RNA complex formation.

FMRP mediates miRNA annealing to specific RNA targets through its KH domains
----------------------------------------------------------------------------

To get further insights into the miRNA annealing properties of FMRP, we assessed the activity of the biologically relevant FMRP I304N mutant and the deleted ΔKHT FMRP version. A single substitution (I304N) in the *Fmr1* gene product FMRP was found in a fragile X patient suffering of a severe form of fragile X syndrome \[[@B37]\]. When the recombinant FMRP I304N mutant protein was tested in RNA strand annealing assays, it exhibited properties comparable to the wild-type protein ([Figure 3(a)](#fig3){ref-type="fig"}). On the other hand, deletion of the KH domains markedly compromised its miRNA annealing properties ([Figure 3(b)](#fig3){ref-type="fig"}). Since the KH domains present in RNA-binding proteins are known to mediate binding to ss nucleic acids, as reviewed recently \[[@B38]\], these results support the requirement of the ssRNA-binding KH domains for FMRP-mediated miRNA annealing to specific RNA targets.

FMRP is required for efficient RNA silencing in mammalian cells
---------------------------------------------------------------

In order to assess whether the activity displayed by FMRP in vitro is important for RNA silencing in vivo, we set up a reporter-based cellular assay using cultured mouse embryonic fibroblasts established from *Fmr1* KO \[[@B24]\] or isogenic wild-type mice. In these assays, a dual reporter gene construct encoding *Renilla* (*Rluc*) and *Firefly* (*Fluc*) luciferase was cotransfected with a construct encoding an shRNA directed against Rluc. We used a second *Fluc* reporter that, in addition to correct for cell-to-cell variability, allowed us to examine the function of FMRP pertaining to small RNA-mediated RNA silencing. This was essential considering that FMRP can act as a negative regulator of translation \[[@B22]--[@B24]\].

Immunoblot analyses of *Fmr1* KO cell protein extracts confirmed the absence of FMRP ([Figure 4(a)](#fig4){ref-type="fig"}, right lane), whereas FMRP was detected in wild-type cells ([Figure 4(a)](#fig4){ref-type="fig"}, left lane). Expression of Rluc shRNA, which had no effect on interferon regulatory factor-1 (IRF-1) protein levels (see Supplementary Data, Figure S1), induced a dose-dependent decrease in Rluc activity in wild-type cells ([Figure 4(b)](#fig4){ref-type="fig"}). The efficiency of Rluc shRNA to induce RNA silencing was significantly impaired in *Fmr1* KO cells, as compared to wild-type cells.

The observed variations in RNA silencing responses might be a consequence of looking at different cell line clones which, apart from being deficient in FMRP, may have different properties with respect to transfection, nucleic acid release, or amount of available Exportin 5 \[[@B39]\] or RISC \[[@B40]\]. A recent study reported that the efficiency of the RNAi pathway may differ between cell types \[[@B41]\]. In order to confirm our data and to avoid possible misinterpretation due to cell line-specific RNA silencing responses, we have tested three additional *Fmr1* KO cell lines (STEK 3T3A, STEK 3T6A, and STEK TpBSVE) and one additional control wild-type cell line (NIH/3T3). The absence or presence of FMRP in these cell lines was confirmed by immunoblot analysis. As shown in [Figure 4(c)](#fig4){ref-type="fig"}, impairment of shRNA-induced Rluc silencing was observed in all *Fmr1* KO cell lines tested, as compared to FMRP-expressing control cell lines. Thus, the observed defect of the RNA silencing pathway in *Fmr1* KO cell lines is not specific to a particular cell line clone, thereby confirming the importance of FMRP for efficient RNA silencing in mammalian cells.

FMRP is essential for ss siRNA-induced RNA silencing
----------------------------------------------------

In order to get further insights into the role of FMRP in RNA silencing, we compared in *Fmr1* KO and wild-type cells the efficiency of two other RNA silencers (siRNA duplex and ss antisense siRNA) that are known to enter the endogenous machinery at levels downstream to that of shRNAs or pre-miRNAs. Duplex siRNA-induced silencing was efficient in wild-type cells, with a \> 90% inhibition of Rluc activity at 100 nM, but was defective in *Fmr1* KO cells (*P* \< .001) ([Figure 5](#fig5){ref-type="fig"}). These results suggest that the defect associated with the absence of FMRP is situated at or downstream of the siRNA duplex entry level into the RNAi pathway.

To characterize this perturbation further, we induced silencing of the Rluc reporter gene by using ss antisense siRNA, which may enter the RNA silencing machinery downstream of the strand selection/separation step(s). In wild-type cells, the extent of Rluc silencing induced by ss antisense Rluc siRNA reached ∼ 35% at the highest concentration ([Figure 5](#fig5){ref-type="fig"}), which was less pronounced than that achieved with the corresponding duplex, as previously reported \[[@B42], [@B43]\]. However, cells lacking FMRP were incompetent at mediating Rluc silencing induced by ss antisense Rluc siRNA (*P* \< .05). These data imply the involvement of FMRP in a distal ss siRNP effector complex in mammalian cells.

The properties of FMRP are shared by its paralog FXR1P
------------------------------------------------------

In contrast to the single *dFMR1* gene in *Drosophila*, three paralogs, namely, FMRP and the fragile X-related proteins FXR1P and FXR2P, are expressed in mammalian cells \[[@B31]\]. In order to examine if the properties of FMRP are unique or representative of this gene family, we studied the function of FXR1P. As illustrated in Figures [6(a)](#fig6){ref-type="fig"} and [6(b)](#fig6){ref-type="fig"}, the miRNA and ss siRNA annealing properties of FXR1P are similar to those exhibited by FMRP in vitro (compare with Figures [2(a)](#fig2){ref-type="fig"} and [2(b)](#fig2){ref-type="fig"}). We then studied the importance of FXR1P in RNA silencing in vivo using *Fxr1* KO cells. Immunoblot analyses confirmed the absence of FXR1P in these cells ([Figure 6(c)](#fig6){ref-type="fig"}, compare right lane versus left lane). As *Fmr1* KO cells, *Fxr1* KO cells also exhibited, although to a lesser extent, a compromised RNA silencing response relative to wild-type cells ([Figure 6(d)](#fig6){ref-type="fig"}). These results suggest a common, possibly complementary, role for members of the fragile X protein family in RNA silencing in mammals.

DISCUSSION
==========

A cooperation between Dicer and FMRP, in which FMRP would act as an acceptor of miRNAs derived from Dicer processing of pre-miRNAs, is consistent with a concerted action in regulating mRNA expression. Independent groups have shown that target cleavage directed by ss siRNA is supported in extracts of HeLa cells \[[@B42], [@B43]\], from which a human RISC containing ss siRNA was characterized \[[@B42]\]. The presence of a single siRNA strand in mRNA-cleaving RNP complexes, previously found to contain dFMR1 \[[@B27], [@B28]\], has also been demonstrated in *Drosophila* S2 cells \[[@B44], [@B45]\]. Although the human and fly RNA silencing machineries differ mechanistically and in terms of mediating translational repression or mRNA cleavage, they may share two features in common: an ssRNA-containing effector RNP complex and a member of the fragile X protein family.

Recent findings indicate that siRNA-bound Dicer-2 assembles into RISC in *Drosophila* \[[@B44]--[@B46]\]. Although the assembly of miRNA-bound Dicer into human RISC remains to be demonstrated, the observations that (i) the product of human Dicer remains associated with the enzyme \[[@B7]\], that (ii) Dicer interacts directly with the human RISC component Ago2 \[[@B47]\], and that (iii) FMRP forms an RNP complex with Ago2 and miRNAs in mammalian cells \[[@B29]\] are compatible with this scenario. This assembly scheme may determine the nature of the RNA species to be loaded into RNPs and confer specificity to the general RNA binding and chaperone properties of FMRP operating in miRNA-mediated RNA silencing. Although a recent study demonstrating the presence of Dicer preassembled in a human RISC that can cleave target RNA by utilization of a pre-miRNA Dicer substrate offers a slightly different perspective \[[@B48]\].

When assessing cellular responses to silencing RNAs, we found that FMRP was required for optimal RNA silencing in mammalian cells, as previously reported in *Drosophila* \[[@B27]\]. Rluc silencing mediated by Rluc shRNA is likely executed by an ss siRNP through a reaction in which the strand annealing properties of FMRP are solicited. This is in agreement with the fact that FMRP is unable to exchange strands of perfectly paired siRNA duplexes to target RNAs in vitro (see Supplementary Data, Figure S2) and recent evidences suggesting the involvement of an ss siRNP in target RNA cleavage mediated by human RISC \[[@B48]\]. Considering the transposition of our in vitro annealing assays, using synthetic RNAs and recombinant proteins, to RNA silencing in vivo, the caveat has to be taken into account that the presence of other protein or nucleic acid components as well as postranslational modifications may influence the role and function of FMRP.

The relative importance of fragile X proteins in RNA silencing observed in our study may have been underestimated given that expression of FXR1P and FMRP may have contributed to alleviate and compensate for their respective functional loss in *Fmr1* and *Fxr1* KO cells. A relatively higher expression levels of FMRP and Dicer in *Fxr1* KO fibroblasts was observed (I Plante and P Provost, unpublished data). This may be related either to a compensatory mechanism, in the case of the former, or a dysfunctional miRNA-based regulation of their expression. The fact that FMRP and FXR1P exhibit similar activities, conjugated with the differential tissue expression patterns of the fragile X proteins observed in mammals, suggests that RNP complexes of various composition may be functionally redundant.

A fragile X patient was found to carry a single substitution (I304N) in the *Fmr1* gene product FMRP. We observed that recombinant FMRP I304N mutant protein exhibited miRNA strand annealing properties comparable to the wild-type protein. In contrast, the ss nucleic acid binding KH domains appear to be required for the miRNA annealing activity of FMRP. However, neither of these two mutants, that is, FMRP ΔKHT \[[@B30]\] and FMRP I304N \[[@B49]\], cosedimented with polyribosomes, thereby dissociating the polyribosomal association and miRNA annealing activity of FMRP. These observations suggest that the phenotype observed in fragile X patients may be related either to the loss of its chaperone activity \[[@B32]\] or the mislocalization of a still active mutant protein, as demonstrated for the FMRP I304N mutant \[[@B49]\].

The hypothesis that the subset of mRNAs bound by FMRP may be subjected to miRNA regulation, as proposed by Jin et al \[[@B50]\], is attractive. FMRP may recognize its target mRNAs through recognition of the G quartet structures \[[@B51], [@B52]\] and/or via the kissing complex motifs \[[@B53]\]. The silencing state of the bound mRNA might then be determined by a specific regulatory miRNA. The specificity of miRNA-based translational regulation may thus reside in both the sequence of the miRNA as well as the recognition of selected mRNA targets by FMRP. In turn, the presence and importance of FMRP in effector miRNP complexes may explain why FMRP is found associated with so many mRNAs. It will be interesting to see what proportion of the several hundreds of mRNAs bound by FMRP \[[@B54], [@B55]\] are experimentally validated and physiologically relevant miRNA targets.

The biological significance of pre-miRNA binding by FMRP (I Plante and P Provost, unpublished data), an event that would occur upstream of Dicer, is unclear. However, it is relevant to note that FMRP contains a nuclear localization signal (NLS) as well as a nuclear export signal (NES) \[[@B56]\]. These sequences appear to be functional, as FMRP was subsequently characterized as a nucleocytoplasmic shuttling protein \[[@B57]\]. Together, these observations raise the possibility that FMRP may play a role in nuclear export of pre-miRNA. The issues as to whether FMRP can be found in processing bodies mediating translation repression, as suggested by trapping of mRNAs by FMRP into cytoplasmic granules \[[@B24]\], or accompanies miRNP complexes involved in other cellular processes requiring mRNA repression, such as transfer of mRNAs from the cell body to dendrites of neurons \[[@B58]\], will also need to be addressed.

Several findings suggest the possible presence of Dicer in FMRP-containing complexes present in the translation machinery: (i) fractionation of competent RISC with ribosomes \[[@B10]\]; (ii) the demonstration that Dicer is part of the human RISC \[[@B48]\]; (iii) the documented existence of polyribosomal miRNAs \[[@B59], [@B60]\]; and (iv) transcripts engaged in translation regulation are sensitive to RNAi \[[@B61]\]. Our findings provide yet another functional link between the initiation and effector steps of RNA silencing.

FMRP may function in RNA silencing as a downstream effector of Dicer and miRNA assembler on target mRNAs. FMRP is particularly abundant in the brain due to its high expression in neurons \[[@B34], [@B62]\], and the extent of neuronal miRNA-mediated mRNA regulation, as deduced by the number and diversity of miRNAs cloned from mammalian neurons \[[@B60]\], appears to be important. A suboptimal miRNA assembly on their natural mRNA targets, resulting from the lack of FMRP expression, may contribute to the molecular basis for the fragile X syndrome, thereby suggesting a causal link between dysfunction of the RNA silencing machinery and a human disease.
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The Supplementary text shows sequence and structure of RNAs used in this study. Supplementary Figure S1 shows that expression of shRNA has no effect on interferon regulatory factor-1 (IRF-1) protein expression and Supplementary Figure S2 shows that FMRP is unable to exchange strands of perfectly paired siRNA duplexes to target RNAs in vitro.
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FMRP can act as an acceptor of miRNA derived from Dicer cleavage of pre-miRNA. (a) Recombinant FMRP interacts with Dicer RNA cleavage products. ^32^P-labeled pre-miR-31 was incubated in the absence or presence of recombinant Dicer, without (left) or with (center) MgCl~2~. The samples were analyzed by nondenaturing (left) or denaturing (center) PAGE and autoradiography. RNA derived from Dicer cleavage was gel-purified and incubated with increasing amounts of recombinant FMRP (0.35--1.4 *μ*g), without or with BSA (20 *μ*g), prior to EMSA analysis (right). M indicates a 10-nt RNA size marker. (b) FMRP preferentially interacts with miRNAs. ^32^P-labeled green fluorescent protein (GFP) siRNA (left), hsa-miR-196a-1 miRNA:miRNA\* duplex (center), or miRNA (right) was incubated in the absence or presence of increasing amounts of recombinant FMRP. The samples were analyzed by EMSA and autoradiography, and analyzed quantitatively by PhosphorImaging. Bound RNA was expressed as a bound to unbound ratio.
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###### 

FMRP preferentially facilitates natural miRNA:target RNA complex formation. FMRP mediates miRNA (a) and siRNA (b) annealing to specific RNA targets. (a) ^32^P-labeled cel-let-7 (left) or hsa-miR-196a-1 (right) was incubated with a specific *lin-41* or *HOXB8* RNA target, respectively, in the absence or presence of increasing amounts of FMRP, or BSA at 4 : 1 (protein:RNA) molar ratio. (b) The RNA strand annealing assays using a single ^32^P-labeled strand of Dicer (left) or CLP (right) siRNA duplex incubated with a specific or nonspecific RNA target were performed as in (a). Control hybridization was conducted at 37°C for 10 min^*a*^ or 65°C for 30 min^*b*^. RNA complexes were analyzed by nondenaturing 10% PAGE and autoradiography. B, BSA; NS, nonspecific target.
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FMRP mediates miRNA annealing to specific RNA targets through its KH domains. RNA strand annealing properties of the FMRP I304N (a) and ΔKHT (b) mutants. (a) ^32^P-labeled hsa-miR-196a-1 miRNA was incubated with a specific *HOXB8* RNA target in the absence or presence of FMRP or FMRP I304N or with BSA at 4 : 1 (protein:RNA) molar ratio. (b) The RNA strand annealing assays using the FMRP ΔKHT mutant were performed as in (a). Control hybridization was conducted at 37°C for 10 min^*a*^ or 65°C for 30 min^*b*^. RNA complexes were analyzed by nondenaturing 10% PAGE and autoradiography. B, BSA; NS, nonspecific *lin-41* RNA target.
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FMRP is required for efficient RNA silencing in mammalian cells. (a) Expression of FMRP in wild-type and *Fmr1* KO (TSV-40) cells was verified by immunoblot analysis, in parallel with actin. (b) *Fmr1* KO (TSV-40) and wild-type (Naïves) cells were cotransfected with psiSTRIKE encoding Rluc shRNA and psiCHECK reporter construct (*n* = 6). (c) *Fmr1* KO cell lines STEK TSV-40 (*n* = 2), STEK 3T3A (*n* = 2), STEK 3T6A (*n* = 1), and STEK TpBSVE (*n* = 2), and wild-type Naïves (*n* = 6) and NIH/3T3 (*n* = 5) cell lines were cotransfected as in (b). Results of Rluc activity were normalized with Fluc activity and expressed as a percentage of Rluc activity obtained with an shRNA directed against a sequence deleted in the Rluc reporter mRNA. Results were expressed as mean ± SEM and analyzed by analysis of variance followed by unpaired Student\'s *t* test. \*\*\**P* \< .001.
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![FMRP is required for ss siRNA-induced RNA silencing. *Fmr1* KO (TSV-40) and wild-type (Naïves) cells were cotransfected with ss antisense Rluc siRNA (asRluc) or Rluc siRNA duplex (siRluc) and psiCHECK reporter construct (*n* = 6). Results were expressed as mean ± SEM and analyzed as described in the legend of [Figure 4](#fig4){ref-type="fig"}. \**P* \< .05; \*\**P* \< .01; \*\*\**P* \< .001.](JBB2006-64347.005){#fig5}

###### 

The paralog FXR1P shares the RNA strand annealing properties of FMRP. (a)-(b) RNA strand annealing assays with FXR1P were performed and analyzed as described in the legend of [Figure 2](#fig2){ref-type="fig"}. (c) Expression of FXR1P in wild-type and *Fxr1* KO cells was verified by immunoblot analysis, in parallel with actin. (D) *Fxr1* KO and wild-type (Naïves) cells were cotransfected with psiSTRIKE encoding Rluc shRNA and psiCHECK reporter construct (*n* = 6). Results were expressed as mean ± SEM and analyzed as described in the legend of [Figure 4](#fig4){ref-type="fig"}. \**P* \< .05; \*\**P* \< .01.
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